Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19, England, January to May 2020
Anika Singanayagam, Monika Patel, André Charlett, et al.
Eurosurveillance (2020) Vol. 25, Iss. 32
Open Access | Times Cited: 885

Showing 1-25 of 885 citing articles:

Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
Jamie Lopez Bernal, Nick Andrews, Charlotte Gower, et al.
New England Journal of Medicine (2021) Vol. 385, Iss. 7, pp. 585-594
Open Access | Times Cited: 2900
Covid-19 Breakthrough Infections in Vaccinated Health Care Workers
Moriah Bergwerk, Tal Gonen, Yaniv Lustig, et al.
New England Journal of Medicine (2021) Vol. 385, Iss. 16, pp. 1474-1484
Open Access | Times Cited: 1364
Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection
Jacqueline Dinnes, Jonathan J Deeks, Ada Adriano, et al.
Cochrane library (2020)
Open Access | Times Cited: 1210
Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study
Jamie Lopez Bernal, Nick Andrews, Charlotte Gower, et al.
BMJ (2021), pp. n1088-n1088
Open Access | Times Cited: 1202
Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study
Anika Singanayagam, Seran Hakki, Jake Dunning, et al.
The Lancet Infectious Diseases (2021) Vol. 22, Iss. 2, pp. 183-195
Open Access | Times Cited: 753
Transmission of SARS-CoV-2: A Review of Viral, Host, and Environmental Factors
Eric A. Meyerowitz, Aaron Richterman, Rajesh T. Gandhi, et al.
Annals of Internal Medicine (2020) Vol. 174, Iss. 1, pp. 69-79
Open Access | Times Cited: 743
Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants
Emma K. Accorsi, Amadea Britton, Katherine E. Fleming-Dutra, et al.
JAMA (2022) Vol. 327, Iss. 7, pp. 639-639
Open Access | Times Cited: 643
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial
Katherine R. W. Emary, Tanya Golubchik, Parvinder K. Aley, et al.
The Lancet (2021) Vol. 397, Iss. 10282, pp. 1351-1362
Open Access | Times Cited: 624
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection
Jacqueline Dinnes, Jonathan J Deeks, Sarah Berhane, et al.
Cochrane library (2021) Vol. 2022, Iss. 7
Open Access | Times Cited: 560
Estimating infectiousness throughout SARS-CoV-2 infection course
Terry C. Jones, Guido Biele, Barbara Mühlemann, et al.
Science (2021) Vol. 373, Iss. 6551
Open Access | Times Cited: 474
Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study
Dan Frampton, Tommy Rampling, Aidan Cross, et al.
The Lancet Infectious Diseases (2021) Vol. 21, Iss. 9, pp. 1246-1256
Open Access | Times Cited: 443
Inflammasome activation in infected macrophages drives COVID-19 pathology
Esen Sefik, Rihao Qu, Caroline Junqueira, et al.
Nature (2022) Vol. 606, Iss. 7914, pp. 585-593
Open Access | Times Cited: 422
Transmission heterogeneities, kinetics, and controllability of SARS-CoV-2
Kaiyuan Sun, Wei Wang, Lidong Gao, et al.
Science (2020) Vol. 371, Iss. 6526
Open Access | Times Cited: 400
Tools and Techniques for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/COVID-19 Detection
Seyed Hamid Safiabadi Tali, Jason J. LeBlanc, Zubi Sadiq, et al.
Clinical Microbiology Reviews (2021) Vol. 34, Iss. 3
Open Access | Times Cited: 335
Impact of vaccination on new SARS-CoV-2 infections in the United Kingdom
Emma Pritchard, Philippa C. Matthews, Nicole Stoesser, et al.
Nature Medicine (2021) Vol. 27, Iss. 8, pp. 1370-1378
Open Access | Times Cited: 317
SARS-CoV-2 viral load and shedding kinetics
Olha Puhach, Benjamin Meyer, Isabella Eckerle
Nature Reviews Microbiology (2022)
Open Access | Times Cited: 302
A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus
William A. Fischer, Joseph J. Eron, Wayne Holman, et al.
Science Translational Medicine (2021) Vol. 14, Iss. 628
Open Access | Times Cited: 297
What reinfections mean for COVID-19
Akiko Iwasaki
The Lancet Infectious Diseases (2020) Vol. 21, Iss. 1, pp. 3-5
Open Access | Times Cited: 254
Effectiveness of COVID-19 vaccines against the B.1.617.2 variant
Jamie Lopez Bernal, Nick Andrews, Charlotte Gower, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 244
Estimating epidemiologic dynamics from cross-sectional viral load distributions
James A. Hay, Lee Kennedy‐Shaffer, Sanjat Kanjilal, et al.
Science (2021) Vol. 373, Iss. 6552
Open Access | Times Cited: 214
Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers
Yoel Angel, Avishay Spitzer, Oryan Henig, et al.
JAMA (2021) Vol. 325, Iss. 24, pp. 2457-2457
Open Access | Times Cited: 209
Molnupiravir, an Oral Antiviral Treatment for COVID-19
William A. Fischer, Joseph J. Eron, Wayne Holman, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 209
Definitions for coronavirus disease 2019 reinfection, relapse and PCR re-positivity
Dafna Yahav, Dana Yelin, Isabella Eckerle, et al.
Clinical Microbiology and Infection (2020) Vol. 27, Iss. 3, pp. 315-318
Open Access | Times Cited: 198
Quarantine and testing strategies in contact tracing for SARS-CoV-2: a modelling study
Billy J. Quilty, Samuel Clifford, Joel Hellewell, et al.
The Lancet Public Health (2021) Vol. 6, Iss. 3, pp. e175-e183
Open Access | Times Cited: 198
Early effectiveness of COVID-19 vaccination with BNT162b2 mRNA vaccine and ChAdOx1 adenovirus vector vaccine on symptomatic disease, hospitalisations and mortality in older adults in England
Jamie Lopez Bernal, Nick Andrews, Charlotte Gower, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 195
Page 1 - Next Page

Scroll to top